Nothing Special   »   [go: up one dir, main page]

FR2539626B2 - Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede - Google Patents

Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede

Info

Publication number
FR2539626B2
FR2539626B2 FR8301115A FR8301115A FR2539626B2 FR 2539626 B2 FR2539626 B2 FR 2539626B2 FR 8301115 A FR8301115 A FR 8301115A FR 8301115 A FR8301115 A FR 8301115A FR 2539626 B2 FR2539626 B2 FR 2539626B2
Authority
FR
France
Prior art keywords
dietetics
therapeutics
cosmetics
diagnosis
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8301115A
Other languages
English (en)
Other versions
FR2539626A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to FR8301115A priority Critical patent/FR2539626B2/fr
Priority to CH1884/83A priority patent/CH654207A5/fr
Priority to US06/482,904 priority patent/US4490407A/en
Priority to CA000425553A priority patent/CA1187795A/fr
Priority to ES521401A priority patent/ES8403718A2/es
Priority to GB08315086A priority patent/GB2133983B/en
Priority to ZA84565A priority patent/ZA84565B/xx
Priority to BE2/60321A priority patent/BE898749A/fr
Priority to AU23789/84A priority patent/AU560897B2/en
Priority to IT19308/84A priority patent/IT1174474B/it
Priority to PT78006A priority patent/PT78006B/pt
Publication of FR2539626A2 publication Critical patent/FR2539626A2/fr
Application granted granted Critical
Publication of FR2539626B2 publication Critical patent/FR2539626B2/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
FR8301115A 1983-01-25 1983-01-25 Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede Expired FR2539626B2 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR8301115A FR2539626B2 (fr) 1983-01-25 1983-01-25 Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
CH1884/83A CH654207A5 (fr) 1983-01-25 1983-04-07 Procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic.
US06/482,904 US4490407A (en) 1983-01-25 1983-04-07 Method for preparing galenic formulations particularly for pharmaceutical, dietetical, cosmetic and diagnostic uses
CA000425553A CA1187795A (fr) 1983-01-25 1983-04-11 Methode de preparation de formules galeniques utilisees en pharmacie, en dietetique, en cosmetologie et pour les diagnostics
ES521401A ES8403718A2 (es) 1983-01-25 1983-04-12 Procedimiento de criodesecacion de sustancias cosmeticas y de diagnostico en solucion o suspension en disolventes.
GB08315086A GB2133983B (en) 1983-01-25 1983-06-01 Method for preparing galenic formulations particularly for pharmaceutical, dietary, cosmetic and diagnostic uses
ZA84565A ZA84565B (en) 1983-01-25 1984-01-25 Method for preparing galenic formulations particularly for pharmaceutical,dietary,cosmetic and diagnosis uses
BE2/60321A BE898749A (fr) 1983-01-25 1984-01-25 Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
AU23789/84A AU560897B2 (en) 1983-01-25 1984-01-25 Galenic formulations
IT19308/84A IT1174474B (it) 1983-01-25 1984-01-25 Procedimento per la preparazione di formulazione galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico
PT78006A PT78006B (en) 1983-01-25 1984-01-25 Process for preparing galenic formulations for pharmaceutical dietary cosmetic and diagnostic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301115A FR2539626B2 (fr) 1983-01-25 1983-01-25 Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede

Publications (2)

Publication Number Publication Date
FR2539626A2 FR2539626A2 (fr) 1984-07-27
FR2539626B2 true FR2539626B2 (fr) 1985-06-21

Family

ID=9285262

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8301115A Expired FR2539626B2 (fr) 1983-01-25 1983-01-25 Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede

Country Status (11)

Country Link
US (1) US4490407A (fr)
AU (1) AU560897B2 (fr)
BE (1) BE898749A (fr)
CA (1) CA1187795A (fr)
CH (1) CH654207A5 (fr)
ES (1) ES8403718A2 (fr)
FR (1) FR2539626B2 (fr)
GB (1) GB2133983B (fr)
IT (1) IT1174474B (fr)
PT (1) PT78006B (fr)
ZA (1) ZA84565B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
IL86892A (en) * 1987-07-08 1993-04-04 Lafon Labor Filter comprising a material obtained by freeze-drying, its preparation and its use, especially in pharmacy
IT1231260B (it) * 1988-11-16 1991-11-28 Sergio Bertini Curri Farmaco e metodo per aumentare volume e velocita' del flusso microcircolatorio capillare a livello cutaneo
MY106919A (en) * 1990-08-31 1995-08-30 Kao Corp Composition for use in oral cavity.
FR2698560B1 (fr) * 1992-11-30 1995-02-03 Virbac Laboratoires Principes actifs pulvérulents stabilisés, compositions les contenant, leur procédé d'obtention et leurs applications.
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5981719A (en) * 1993-03-09 1999-11-09 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
FR2703588B1 (fr) * 1993-04-05 1995-06-23 Oreal Composition granulee a base de derives peroxydes utilisable pour la decoloration des cheveux et procede de preparation de ladite composition.
DE4317172A1 (de) * 1993-05-22 1995-01-05 Rhone Poulenc Rorer Gmbh Geschmacksneutrale und schnellfreisetzende Buflomedil-Hydrochlorid-Arzneiform und Herstellungsverfahren desselben
FR2740357B1 (fr) * 1995-10-25 1997-11-28 Rhone Poulenc Chimie Granules redispersables dans l'eau comprenant une matiere active sous forme liquide et un tensio-actif non ionique du type alcoxyles
US5686133A (en) * 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
AU2001257359A1 (en) 2000-04-27 2001-11-07 Verion Inc. Zero order release and temperature-controlled microcapsules and process for the preparation thereof
US6541030B2 (en) 2000-09-27 2003-04-01 Verion Inc. Instant water dissolvable encapsulate and process
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US20080031947A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. Orally dissolvable/disintegrable lyophilized dosage forms containing protected
EP2359812A1 (fr) 2010-01-18 2011-08-24 Cephalon France Compositions orales lyophilisées
WO2011086194A1 (fr) 2010-01-18 2011-07-21 Cephalon France Lyophilisats oraux améliorés contenant un copolymère de pvp/va
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1289430A (fr) * 1960-04-04 1962-04-06 Perfectionnement aux techniques d'enrobage de principes médicamenteux et produits ainsi obtenus
GB1227744A (fr) * 1967-07-04 1971-04-07
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
CH528266A (fr) * 1969-11-26 1972-09-30 Orsymonde Procédé pour la préparation d'une composition lyophilisée à l'usage cosmétique ou hygiénique
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
BE786307A (fr) * 1971-07-16 1973-01-15 Ciba Geigy Procede d'encapsulation de substances finement dispersees dans un liquide selon le procede de condensation par atomisation
GB1482785A (en) * 1974-10-30 1977-08-17 Du Pont Method of preparing a homogeneous lyophilised composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating

Also Published As

Publication number Publication date
AU2378984A (en) 1984-07-26
FR2539626A2 (fr) 1984-07-27
GB8315086D0 (en) 1983-07-06
US4490407A (en) 1984-12-25
IT1174474B (it) 1987-07-01
ES521401A0 (es) 1984-04-01
CH654207A5 (fr) 1986-02-14
GB2133983B (en) 1986-11-05
PT78006B (en) 1986-03-27
ES8403718A2 (es) 1984-04-01
PT78006A (en) 1984-02-01
BE898749A (fr) 1984-05-16
GB2133983A (en) 1984-08-08
ZA84565B (en) 1984-09-26
IT8419308A0 (it) 1984-01-25
AU560897B2 (en) 1987-04-16
CA1187795A (fr) 1985-05-28

Similar Documents

Publication Publication Date Title
FR2539626B2 (fr) Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic, et formes obtenues selon ce procede
IT1190929B (it) Diidropiridine dotate di azione inotropa positiva,composti,loro impiego in prodotti medicinali e procedimento per la loro preparazione
IT1095577B (it) Eccipiente per uso nella preparazione di prodotti farmaceutici allo stato solido
LU79335A1 (fr) Procede de preparation de derives d'acetamides utiles notamment en therapeutique
IT8423449A0 (it) Indicatori stabilizzati per rivelare l'attivita' di enzimi e procedimenti per la loro preparazione ed uso.
FR2600064B1 (fr) Composes benzopyrannyl et benzothiopyrannyl benzoiques, leur procede de preparation et leur utilisation en cosmetique et en medecine humaine et veterinaire
DE2861289D1 (en) Imidazolidine derivatives, process for their preparation, intermediates for use in this process, pharmaceutical compositions containing them and the use of the active compounds
BE864112A (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
GB2175204A (en) Skin regenerating and hydrating cosmetic compositions and process for the preparation of the active ingredient
IT7825897A0 (it) Polieteri, procedimenti per la loro preparazione e loro impiego come prodotti che inibiscono l'assorbimento di lipidi.
IL60613A (en) Dermatological compositions applicable directly to the skin comprising an eburnamenine derivative and process for their preparation
FR2571364B1 (fr) Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede
FR2353556A1 (fr) Derives de l'acide clavulanique, leur procede de preparation et leur application en therapeutique
FR2612396B1 (fr) Compositions cosmetiques regenerant la peau et leur procede de preparation
MA19907A1 (fr) Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques.
DE3066533D1 (en) Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions
IE782515L (en) Treating diarrhoea
IT8249558A0 (it) Preparato per ridurre traumi dei tessuti in esseri umani o animali e procedeminto per la sua produzione
IT1133086B (it) Preparato medicinale per trattare carcinomi e procedimento per la sua produzione
FR2549835B1 (fr) Acides peneme-carboxyliques, leur preparation et leur utilisation therapeutique, notamment en tant qu'agents antibacteriens
FR2305412A1 (fr) Procede de preparation d'a-phenylglycines optiquement actives et composes intermediaires dans ledit procede
BE851961A (fr) Procede de preparation de la 9, 10-dihydroergosine et de sels d'addition d'acides physiologiquement acceptables de cette derniere et leur emploi en medecine
BE853332A (fr) Nouveaux sels d'addition d'acides du d-(+)-1-(3-hydroxyphenyl)-2-amino-propane, utiles notamment comme sympathomimetiques, et leur procede de preparation
PT72114A (fr) Procede de preparation de derives benzylideniques applicables en therapeutique